Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Therapeutic Pipeline Program, 2017
    Cell-Permeable Parkin Protein Suppresses Parkinson's Disease-associated Symptoms

    Study Rationale:
    The Parkin protein (encoded by the PARK2 gene that is linked to Parkinson's), has been shown to exert potent neuroprotective effects that could potentially be used to treat Parkinson's...

  • Research Grant, 2017
    Promoting Mitochondrial Transport in Dopaminergic Neurons

    Study Rationale:
    Healthy mitochondria (powerhouses of the cell) are crucial to the survival of neurons, and poorly-functioning mitochondria are implicated in the neurodegeneration associated with...

  • Target Advancement Program, 2017
    Preventing Misfolded Alpha-synuclein Accumulation

    Study Rationale:
    The pathological hallmark of Parkinson's disease (PD) is the widespread accumulation of cellular deposits (Lewy Bodies) comprised of clumps of a misfolded protein called alpha...

  • Improved Biomarkers and Clinical Outcome Measures, 2017
    Regulation of the SNCA Gene in Parkinson's Disease

    Study Rationale:
    DNA methylation is a regulatory mechanism that can turn genes on or off within the cells in our body. In Parkinson's disease (PD), methylation near SNCA (a gene linked to PD) is lower...

  • Research Grant, 2017
    Imaging Agents for Tauopathies and Alpha-Synuclein

    Study Rationale:
    Assessing the accumulation of tau (protein associated with dementia) and alpha-synuclein (sticky protein associated with Parkinson's) in the living human brain is crucial to better...

  • Research Grant, 2017
    The RESISTA-PD trial - The Effects of Resistant Starch on Bowel Habits, Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease

    Study Rationale:
    Individuals with Parkinson's disease (PD) frequently suffer from constipation; those with PD also have altered bacterial composition in the gut. The RESISTA-PD trial investigates...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.